October 13, 2022 Western States Scientific Safety Review Workgroup Recommends the Use of COVID-19 Bivalent Boosters for Pediatric Population The Western States Scientific Safety Review Workgroup recommends the use of the Moderna and Pfizer COVID-19 Bivalent Boosters in younger age groups, in accord
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

October 13, 2022

Western States Scientific Safety Review Workgroup Recommends the Use of COVID-19 Bivalent Boosters for Pediatric Population

 

The Western States Scientific Safety Review Workgroup recommends the use of the Moderna and Pfizer COVID-19 Bivalent Boosters in younger age groups, in accordance with federal authorization by FDA and recommendations from CDC. Providers may administer the COVID-19 Bivalent Boosters to eligible pediatric populations and should stop administering the monovalent vaccine as a booster. Giving a dose of monovalent vaccine as a booster is now considered to be an administration error.



Eligibility

  • Moderna Bivalent Booster is authorized and recommended for those 6 years and older. This is the same product that was previously authorized for those 18 years and older.
  • Pfizer Pediatric Bivalent Booster is authorized and recommended for those 5 years to 11 years. This is a different product from the Pfizer Bivalent Booster that was previously authorized for those 12 years and older.
  • A bivalent booster should only be given to persons who have completed their primary series - please see the timing information below.
  • The bivalent booster recommendation replaces previous booster recommendations for people 5 years and older. 

Timing

Administer at least 2 months after completion of the primary series or the most recent booster dose of an FDA approved or authorized monovalent (original) COVID-19 vaccine. Please refer to CDC clinical guidance for additional considerations on timing of the bivalent booster dose.


Monovalent Vaccine - Initial Series Only for 5+ Years

Monovalent Moderna and Pfizer vaccines are no longer authorized as a booster dose for those 5 years and older, but continue to be authorized for primary series vaccination of those 6 months and older. 


My Turn and myCAvax Updates 

Updates to My Turn and myCAvax will be released to reflect the new product groupings and updated ages.


Resources

  • FDA Authorizes Bivalent COVID-19 Vaccines for Use in Younger Age Groups
  • Updated CDC Interim Clinical Recommendations for the Use of COVID-19 Vaccines 
  • CDC Vaccine Administration Errors
  • Updated COVID-19 Vaccination Program Provider Operations Manual
  • Pfizer Vaccine, Bivalent 5-11Y Fact Sheet
  • Moderna Vaccine, Bivalent 6Y+ Fact Sheet


 

View Archived Messages

‌COVID19 Vaccination Program

‌‌California Department of Public Health | Immunization Branch
850 Marina Bay Pkwy
Richmond CA 94804

View In Browser

Copyright @Microsoft Dynamics, All right reserved.

850 Marina Bay Parkway, Bldg P Richmond CA 94804

Unsubscribe